Brian Silver
2021
In 2021, Brian Silver earned a total compensation of $3.2M as Chief Financial Officer and Treasurer at TScan Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $122,000 |
|---|---|
| Option Awards | $2,739,017 |
| Salary | $305,000 |
| Other | $16,969 |
| Total | $3,182,986 |
Silver received $2.7M in option awards, accounting for 86% of the total pay in 2021.
Silver also received $122K in non-equity incentive plan, $305K in salary and $17K in other compensation.
Rankings
In 2021, Brian Silver's compensation ranked 4,204th out of 12,415 executives tracked by ExecPay. In other words, Silver earned more than 66.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,204 out of 12,415 | 66th |
Division Manufacturing | 1,730 out of 5,505 | 69th |
Major group Chemicals And Allied Products | 720 out of 2,375 | 70th |
Industry group Drugs | 642 out of 2,096 | 69th |
Industry Biological Products, Except Diagnostic Substances | 167 out of 449 | 63rd |
Source: SEC filing on April 25, 2023.
Silver's colleagues
We found two more compensation records of executives who worked with Brian Silver at TScan Therapeutics in 2021.